MedTrace Logo

Simultaneous Engagement of Networks for Alleviating Pain (SENAP)

NCT07057206 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-01-07

No results posted yet for this study

Summary

This trial is investigating the acceptability and efficacy of PFM-guided cortical stimulation for the treatment of central neuropathic pain.

Conditions

  • Neuropathic Pain
  • Postherpetic Neuralgia

Interventions

DEVICE

PFM-guided cortical stimulation

Abbott Eterna IPG and Lamitrode 44 paddles with accessory extensions and clinical programmers

Sponsors & Collaborators

Principal Investigators

  • David Darrow, MD · University of Minnesota

  • Alexander Herman, MD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2030-12-31
Completion
2030-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07057206 on ClinicalTrials.gov